Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia CastelliniOncologia Ematologia Pediatrica “Lalla Seràgnoli”, Clinica Pediatrica, Università degli Studi di Bologna, Bologna, ItalyAbstract: Along with hydration and urinary alkalinization, allopurinol...
Guardado en:
Autores principales: | Andrea Pession, Fraia Melchionda, Claudia Castellini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4b726773fb0479fa170b61d8acf5fbd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Urate oxidase purification by salting-in crystallization: towards an alternative to chromatography.
por: Marion Giffard, et al.
Publicado: (2011) -
Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout
por: Philip K. Tan, et al.
Publicado: (2017) -
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
por: Kazi Mirajul Hoque, et al.
Publicado: (2020) -
Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
por: Yao Xue, et al.
Publicado: (2021) -
Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice
por: Maimaiti Yisireyili, et al.
Publicado: (2017)